Cargando…
The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients
AIM: To discuss the evaluation value of CT in the efficacy of neoadjuvant chemotherapy in patients with ovarian cancer. METHODS: The clinical, pathological, and CT imaging information of 72 patients with ovarian cancer treated in our hospital from January 2018 to January 2022 were retrospectively an...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200539/ https://www.ncbi.nlm.nih.gov/pubmed/35800240 http://dx.doi.org/10.1155/2022/7195888 |
_version_ | 1784728083557777408 |
---|---|
author | Mou, Daying Xie, Shengyan Li, Pingyuan |
author_facet | Mou, Daying Xie, Shengyan Li, Pingyuan |
author_sort | Mou, Daying |
collection | PubMed |
description | AIM: To discuss the evaluation value of CT in the efficacy of neoadjuvant chemotherapy in patients with ovarian cancer. METHODS: The clinical, pathological, and CT imaging information of 72 patients with ovarian cancer treated in our hospital from January 2018 to January 2022 were retrospectively analyzed. CT examination and pathological examination were compared to evaluate the efficacy of neoadjuvant chemotherapy. RESULTS: Using the CRS grading system, 26 cases (36.11%) scored 1, 42 cases (58.33%) scored 2, and 4 cases (5.56%) scored 3. CRS grading system scores of 1, 2, 3, and 4–7 patients were compared, P > 0.05. The CT manifestations of lymphadenectasis, degree of peritoneal thickening, ascites, and maximum length diameter of the mass were compared between the patients before and after chemotherapy, P < 0.05. According to RECIST 1.1, there were 1 (1.39%) CR, 38 (52.78%) PR, 29 (40.28%) SD, and 4 (5.56%) PD. The comparison was done between RECIST 1.1 and CRS grading system, P > 0.05. CONCLUSION: CT could be used to evaluate the efficacy of neoadjuvant chemotherapy for ovarian cancer. |
format | Online Article Text |
id | pubmed-9200539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-92005392022-07-06 The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients Mou, Daying Xie, Shengyan Li, Pingyuan Contrast Media Mol Imaging Research Article AIM: To discuss the evaluation value of CT in the efficacy of neoadjuvant chemotherapy in patients with ovarian cancer. METHODS: The clinical, pathological, and CT imaging information of 72 patients with ovarian cancer treated in our hospital from January 2018 to January 2022 were retrospectively analyzed. CT examination and pathological examination were compared to evaluate the efficacy of neoadjuvant chemotherapy. RESULTS: Using the CRS grading system, 26 cases (36.11%) scored 1, 42 cases (58.33%) scored 2, and 4 cases (5.56%) scored 3. CRS grading system scores of 1, 2, 3, and 4–7 patients were compared, P > 0.05. The CT manifestations of lymphadenectasis, degree of peritoneal thickening, ascites, and maximum length diameter of the mass were compared between the patients before and after chemotherapy, P < 0.05. According to RECIST 1.1, there were 1 (1.39%) CR, 38 (52.78%) PR, 29 (40.28%) SD, and 4 (5.56%) PD. The comparison was done between RECIST 1.1 and CRS grading system, P > 0.05. CONCLUSION: CT could be used to evaluate the efficacy of neoadjuvant chemotherapy for ovarian cancer. Hindawi 2022-06-08 /pmc/articles/PMC9200539/ /pubmed/35800240 http://dx.doi.org/10.1155/2022/7195888 Text en Copyright © 2022 Daying Mou et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Mou, Daying Xie, Shengyan Li, Pingyuan The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients |
title | The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients |
title_full | The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients |
title_fullStr | The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients |
title_full_unstemmed | The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients |
title_short | The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients |
title_sort | evaluation value of ct in the efficacy of neoadjuvant chemotherapy in ovarian cancer patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200539/ https://www.ncbi.nlm.nih.gov/pubmed/35800240 http://dx.doi.org/10.1155/2022/7195888 |
work_keys_str_mv | AT moudaying theevaluationvalueofctintheefficacyofneoadjuvantchemotherapyinovariancancerpatients AT xieshengyan theevaluationvalueofctintheefficacyofneoadjuvantchemotherapyinovariancancerpatients AT lipingyuan theevaluationvalueofctintheefficacyofneoadjuvantchemotherapyinovariancancerpatients AT moudaying evaluationvalueofctintheefficacyofneoadjuvantchemotherapyinovariancancerpatients AT xieshengyan evaluationvalueofctintheefficacyofneoadjuvantchemotherapyinovariancancerpatients AT lipingyuan evaluationvalueofctintheefficacyofneoadjuvantchemotherapyinovariancancerpatients |